Search

Search Constraints

You searched for: Author/Creator Nativel, Brice

Search Results

1. A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. (August 2017)

2. A hemorrhagic transformation model of mechanical stroke therapy with acute hyperglycemia in mice. Issue 6 (7th January 2018)

3. A small molecule inhibitor of PCSK9 that antagonizes LDL receptor binding via interaction with a cryptic PCSK9 binding groove. Issue 6 (15th March 2020)

4. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA. Issue 2 (23rd July 2019)

5. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. (January 2020)

6. Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function. (June 2021)

7. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk. (7th February 2022)

8. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab. Issue 3 (March 2018)

9. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Issue 9 (28th July 2021)

10. PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke. Issue 9 (September 2021)